Beta thalassemia intermedia
Information
- Disease name
- Beta thalassemia intermedia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01609595 | Completed | Phase 2 | Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand | March 2012 | December 2012 |
| NCT01642758 | Completed | Phase 2 | Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon | May 2012 | January 2013 |
| NCT04432623 | Recruiting | Phase 1/Phase 2 | The BENeFiTS Trial in Beta Thalassemia Intermedia | October 5, 2020 | February 28, 2025 |
| NCT01571635 | Terminated | Phase 2 | Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. | October 10, 2012 | May 24, 2022 |
| NCT04059406 | Terminated | Phase 2 | Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) | September 24, 2020 | March 28, 2023 |